在1型糖尿病中,静止剂治疗和神经病变:一个横截面研究
Raabya Pasha1,2,3, Anoushka Kamath1,3, Zara Linn1,3
1Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Diabetes, obesity & metabolism
|July 24, 2025
概括
在1型糖尿病 (T1DM) 患者的他类药物治疗没有恶化糖尿病外围神经病变 (DPN) 或心脏自主神经病变 (CAN) 的措施. 尽管糖尿病持续时间较长,BMI较高,但他类药物使用者表现出与非使用者的神经病症结果相似.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
背景情况:
- 脱脂症是糖尿病外围神经病变 (DPN) 发病的一个关键因素.
- 类药物对于糖尿病患者的心血管健康至关重要,但它们的神经毒性潜力仍在争论中.
- 1型糖尿病 (T1DM) 患者有神经病变的风险.
研究的目的:
- 调查他类药物使用对T1DM患者神经病变的影响.
- 为了在T1DM患者中比较DPN和心脏自主神经病变 (CAN),有和没有他类药物治疗.
- 在T1DM中评估他类药物的神经毒性作用.
主要方法:
- 评估了160名T1DM患者和64名健康对照.
- 神经病的评估包括症状/临床评估,角膜共聚焦显微镜 (CCM) 和心脏自主功能测试.
- T1DM患者被分为非他类药物治疗 (n=68) 和他类药物治疗 (n=92) 两组.
主要成果:
- 与对照组相比,T1DM患者的神经病症得分显著提高,角膜神经纤维密度降低.
- 尽管年龄较大,BMI较高,糖尿病持续时间较长,但接受他类药物治疗的T1DM患者的DPN和CAN测量与非他类药物使用者相比较.
- 在糖尿病神经病症症状评分,神经病症残疾评分和他类药物组之间的30:15比率中观察到微小的差异.
结论:
- T1DM患者经历了显著的神经病症症状,残疾和神经纤维损失.
- 对于T1DM患者的DPN和CAN,静止剂治疗似乎是安全的.
- 达丁类药物的使用没有加剧T1DM的神经病变,即使糖尿病持续时间较长和BMI较高.
更多相关视频
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Management and Pharmacotherapy
393
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
393
Peripheral Artery Disease IV: Nursing Management
44
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
44
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
875
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
875
Atherosclerosis IV: Nursing Management
51
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
51


